Use of EBPT in Critically Ill Patients With AKI and/or Multiorgan Failure
Key facts
- Who runs it
- Careggi Hospital
- Where
- Italy15 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 1,000 people, planned
- Started
- 16 Jul 2019
- Planned end
- 30 Sept 2025
- Type of study
- Observational
- Treatments tested
- Commercial membrane for Extracorporeal Blood Purification Therapy (EBPT)
- Record updated
- 12 February 2025
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- critically ill patients in the ICU
- one of this EPB therapy:
- CRRT/IHD/Hybrid therapies for support//replacement renal function
- immunomodulation achieved by "high cut-off membranes", "endotoxins and/or cytokines adsorbent membranes" or by high-volume hemofiltration
Who cannot take part
- patients treated only by Cytosorb® and/or Toraymyxin® therapies
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The use of extracorporeal blood purification therapies (EBPT) is becoming increasingly widespread worldwide in everyday clinical practice, particularly in the critical care setting. Nonetheless, most of the clinical trials aimed at exploring the effect of EBPT on patients' long-term outcomes have failed to demonstrate consistent results regarding 28 day- or hospital- mortality rates. The aim of this observational prospective registry is to evaluate if there is a cluster of critically ill patients that mostly benefits from extracorporeal blood purification therapies with different EBPTs.
The group in the trial
- Critically ill patients
In centres that obtained IRB approval for this prospective study, all critically ill patients undergoing EBPTs for support/replacement renal function or immunomodulation will be prospectively observed.
Treatment: Commercial membrane for Extracorporeal Blood Purification Therapy (EBPT)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Use of EBPT in Critically Ill Patients With AKI and/or Multiorgan Failure: a Multicenter Prospective Observational Registry
- Record updated
- 12 February 2025